Griffin Canning’s Future Hangs in the Balance: Which Team Will Take the Gamble?
The baseball world is buzzing with speculation as free agent right-hander Griffin Canning finds himself at the center of attention, with both the St. Louis Cardinals and the New York Mets expressing interest, according to Jon Heyman of the New York Post. But here's where it gets intriguing: Canning’s journey has been a rollercoaster of highs and lows, leaving teams to weigh his undeniable potential against a history of injuries. Could he be the missing piece for a contender, or is he a risky bet? Let’s dive in.
After a promising start to the 2025 season with the Mets, Canning’s campaign took a devastating turn when he suffered a torn Achilles tendon in May. Prior to the injury, he had been a standout performer, posting a stellar 2.47 ERA through his first nine starts, with impressive strikeout (23.2%) and ground-ball (55.2%) rates. Even advanced metrics like SIERA (3.84) and FIP (3.92) painted him as a reliable mid-rotation arm. But the injury not only cut his season short but also left teams wondering: Can he stay healthy?
And this is the part most people miss: Canning’s injury history isn’t limited to his Achilles. Over the years, he’s battled elbow, groin, and calf issues, raising questions about his durability. Yet, his talent is undeniable. A former second-round pick by the Angels, Canning has shown flashes of the brilliance that made him a highly touted prospect. The Mets, who signed him to a one-year deal last winter, saw enough to believe in his potential—until fate intervened.
Controversial Take Alert: Some argue that Canning’s injury-prone nature makes him a risky investment, while others believe his upside is worth the gamble. What do you think? Is he a high-reward signing or a cautionary tale?
The Mets and Cardinals both have compelling reasons to pursue Canning. For the Mets, he’s a known quantity who thrived under their coaching staff’s guidance. With rotation depth in question and trade rumors swirling around Kodai Senga and David Peterson, Canning could be a familiar face to fill the void. Meanwhile, the Cardinals, in the early stages of a rebuild, see him as a veteran arm with trade potential. Their current rotation is a mix of unproven talent and prospects, making Canning’s experience and upside an attractive addition.
One thing is certain: Canning’s market value has likely increased since last winter’s $4.25MM deal, assuming he’s fully recovered. Heyman reports he’s expected to be ready “around” Opening Day, though an IL stint remains possible. For teams like the Cardinals and Mets, the question isn’t just about his health—it’s about whether he can regain the form that made him a standout earlier in his career.
Thought-Provoking Question: If you’re a GM, do you take a chance on Griffin Canning’s potential, or do you play it safe with a more consistent option? Let us know in the comments below!
As the offseason unfolds, one thing is clear: Griffin Canning’s story is far from over. Whether he becomes a key piece in a team’s success or a footnote in their rebuild, his journey will be one to watch. Will he rise to the occasion, or will injuries continue to derail his path? Only time will tell.
